A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa

References

• Ugwu NI. Sickle cell disease: awareness, knowledge and attitude among undergraduate students of a Nigerian tertiary educational institution. Asian J Med Sci. 2016;7(5):87–92. doi:10.3126/ajms.v7i5.15044
   Google Scholar
• Onoja SO, Eluke BC, Dangana A, Musa S, Abdullah IN. Evaluation of von Willebrand factor and other coagulation homeostasis profile of patients with sickle cell anemia attending a tertiary hospital at Enugu, Nigeria. Med J Zambia. 2020;47(4):269–275. doi:10.55320/mjz.47.4.715
   Google Scholar
• Aliyu ZY, Kato GJ, Taylor J, et al. Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. Am J Hematol. 2008;83(1):63–70. doi:10.1002/ajh.21057
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. InSeminars in thrombosis and hemostasis. Thieme Med Pub. 2011;37(3):226–236. doi:10.1055/s-0031-1273087
   Google Scholar
• Malowany JI, Butany J. Pathology of sickle cell disease. Semin Diagn Pathol. 2012;29(1):49–55. doi:10.1053/j.semdp.2011.07.005
   PubMed Web of Science ®Google Scholar
• Hsu L, Nnodu OE, Brown BJ, et al. White paper: pathways to progress in newborn screening for sickle cell disease in Sub-Saharan Africa. J Trop Dis Public Health. 2018;6(2):260. doi:10.4172/2329-891X.1000260
   PubMedGoogle Scholar
• Global Burden of Disease Study. Collaborators (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013”. Lancet. 2013;386(9995):743–800. doi:10.1016/s0140-6736(15)60692-4
   Web of Science ®Google Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. doi:10.1016/s0140-6736(10)61029-x
   PubMed Web of Science ®Google Scholar
• Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–151. doi:10.1016/S0140-6736(12)61229-X
   PubMed Web of Science ®Google Scholar
• Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20(1):62–65. doi:10.1111/j.1365-3148.2009.00943.x
   PubMed Web of Science ®Google Scholar
• Afolayan JA, Jolayemi FT. Parental attitude to children with sickle cell disease in selected health facilities in Irepodun Local Government, Kwara State, Nigeria. Stud Ethno Med. 2011;5(1):33–40. doi:10.1080/09735070.2011.11886389
   Google Scholar
• Kadima BT, Gini Ehungu JL, Ngiyulu RM, Ekulu PM, Aloni MN. High rate of sickle cell anaemia in S ub‐S aharan A frica underlines the need to screen all children with severe anaemia for the disease. Acta Paediatr. 2015;104(12):1269–1273. doi:10.1111/apa.13040
   PubMed Web of Science ®Google Scholar
• Fleming AF, Storey J, Molineaux L, Iroko EA, Attai ED. Abnormal haemoglobins in the Sudan savanna of Nigeria: i. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol. 1979;73(2):161–172. doi:10.1080/00034983.1979.11687243
   PubMed Web of Science ®Google Scholar
• Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6(1):23–28. doi:10.1093/inthealth/iht022
   PubMed Web of Science ®Google Scholar
• Ofakunrin AO, Oguche S, Adekola K, et al. Effectiveness and safety of hydroxyurea in the treatment of sickle cell anaemia children in Jos, North Central Nigeria. J Trop Pediatr. 2020;66(3):290–298. doi:10.1093/tropej/fmz070
   PubMed Web of Science ®Google Scholar
• Adewoyin AS, Oghuvwu OS, Awodu OA. Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient’s compliance. Afr Health Sci. 2017;17(1):255–261. doi:10.4314/ahs.v17i1.31
   PubMed Web of Science ®Google Scholar
• Halsey C, Roberts IA. The role of hydroxyurea in sickle cell disease. Br J Haematol. 2003;120(2):177–186. doi:10.1046/j.1365-2141.2003.03849.x
   PubMed Web of Science ®Google Scholar
• Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. J Am Soc Hematol. 2012;120(22):4304–4310. doi:10.1182/blood-2012-03-419879
   Google Scholar
• Galadanci NA, Umar Abdullahi S, Vance LD, et al. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial). Am J Hematol. 2017;92(8):780–788. doi:10.1002/ajh.24770
   PubMed Web of Science ®Google Scholar
• Tshilolo L, Tomlinson G, Williams TN, et al. Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. N Engl J Med. 2019;380(2):121–131. doi:10.1056/NEJMoa1813598
   PubMed Web of Science ®Google Scholar
• Wambebe CO, Bamgboye EA, Badru BO, et al. Efficacy of niprisan in the prophylactic management of patients with sickle cell disease. Curr Ther Res. 2001;62(1):26–34. doi:10.1016/S0011-393X(01)80039-4
   Web of Science ®Google Scholar
• George IO, Frank-Briggs A, Odigie JO. Nicosan therapy: any role in children with sickle cell anemia in Nigeria. Int J Trop Med. 2011;6(6):121–123.
   Google Scholar
• Iyamu EW, Turner EA, Asakura T. In vitro effects of NIPRISAN (Nix‐0699): a naturally occurring, potent antisickling agent. Br J Haematol. 2002;118(1):337–343. doi:10.1046/j.1365-2141.2002.03593.x
   PubMed Web of Science ®Google Scholar
• Oniyangi O, Cohall DH. Phytomedicines (medicines derived from plants) for sickle cell disease. Cochrane Database Syst Rev. 2020;9. doi:10.1002/14651858.CD004448.pub7
   PubMedGoogle Scholar
• Rahimy MC, Gangbo A, Ahouignan G, Adjou R, Deguenon C, Goussanou S. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood. 2003;102:834–838. doi:10.1182/blood-2002-05-1453
   PubMed Web of Science ®Google Scholar
• Ohaeri JU, Shokunbi WA. Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting. J Natl Med Assoc. 2002;94(12):1058–1070.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Edun B, Oreagba IA. Acute pain management in children with sickle cell anaemia during emergency admission to a teaching hospital in Lagos, Nigeria. S Afr J Child Health. 2015;9(4):119–123. doi:10.7196/SAJCH.2015.v9i4.968
   Google Scholar
• Kambale-Kombi P, Marini Djang’eing’a R, Alworong’a Opara JP, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S. Students’ knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo. Hematology. 2020;25(1):91–94. doi:10.1080/16078454.2020.1727174
   PubMed Web of Science ®Google Scholar
• Mukinayi MB, Tumba DG, Gulbis B. Sickle cell disease in the democratic republic of Congo: assessing physicians’ knowledge and practices. Trop Med Infect Dis. 2020;5(3):127. doi:10.3390/tropicalmed5030127
   PubMedGoogle Scholar
• Obed SA, Asah-Opoku K, Aboagye S, Torto M, Oppong SA, Nuamah MA. Awareness of sickle cell trait status: a cross-sectional survey of antenatal women in Ghana. Am J Trop Med Hyg. 2017;96(3):735–740. doi:10.4269/ajtmh.16-0396
   PubMed Web of Science ®Google Scholar
• Boadu I, Addoah T. Knowledge, beliefs and attitude towards sickle cell disease among university students. J Community Med Health Educ. 2018;8(1):1000593. doi:10.4172/2161-0711.1000593
   Google Scholar
• Kambale-Kombi P, Marini Djang’eing’a R, Alworong’a Opara JP, et al. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematology. 2021;26(1):199–205. doi:10.1080/16078454.2021.1880752
   PubMed Web of Science ®Google Scholar
• Mukinayi BM, Kalenda DK, Mbelu S, Gulbis B. Awareness and attitudes of 50 Congolese families affected by sickle cell disease: a local survey. Pan Afr Med J. 2018;29:24. doi:10.11604/pamj.2018.29.24.12276
   PubMed Web of Science ®Google Scholar
• Katawandja AL. Knowledge and practices of health providers on the diagnosis and biological monitoring of sickle cell disease in the City of Kindu, in the East of the Democratic Republic of Congo. Open Access Libr J. 2020;7:e6757. doi:10.4236/oalib.1106757
   Google Scholar
• Ngwengi NY, Fon PN, Mbanya D. Distribution of haemoglobin genotypes, knowledge, attitude and practices towards sickle cell disease among unmarried youths in the Buea Health District, Cameroon. Pan Afr Med J. 2020;37:109. doi:10.11604/pamj.2020.37.109.17864
   PubMed Web of Science ®Google Scholar
• Bazuaye GN, Olayemi EE. Knowledge and attitude of senior secondary school students in Benin City Nigeria to sickle cell disease. World J Medical Sci. 2009;4(1):46–49.
   Google Scholar
• Olakunle OS, Kenneth E, Olakekan AW, Adenike OB. Knowledge and attitude of secondary school students in Jos, Nigeria on sickle cell disease. Pan Afr Med J. 2013;15(1). doi:10.11604/pamj.2013.15.127.2712
   PubMedGoogle Scholar
• Hussaini MA, Durbunde AA, Jobbi YD, et al. Assessment of experience, perception and attitude towards premarital sickle cell disease screening among students attending federal college of education, Kano, Nigeria. Int J Res Rep Hematol. 2019;4:1–2. doi:10.11604/pamj.2021.38.350.20894
   Google Scholar
• Alao OO, Araoye M, Ojabo C. Knowledge of sickle cell disease and haemoglobin electrophoresis: a survey of students of a tertiary institution. Niger J Med. 2009;18(3):326–329. doi:10.4314/njm.v18i3.51208
   PubMedGoogle Scholar
• Abioye-Kuteyi EA, Osakwe C, Oyegbade O, Bello I. Sickle cell knowledge, premarital screening and marital decisions among local government workers in Ile-Ife, Nigeria. Afr J Prim Health Care Fam Med. 2009;1(1):1–5. doi:10.4102/phcfm.v1i1.22
   Google Scholar
• Otovwe A, Sunday UI, Oghenenioborue Rume OB, Awulo DM. Knowledge and attitude of premarital genotype screening among women of child-bearing age in kumo-akko local government area of Gombe State Nigeria. Open J Public Health. 2019;1(2):1006.
   Google Scholar
• Babalola OA, Chen CS, Brown BJ, Cursio JF, Falusi AG, Olopade OI. Knowledge and health beliefs assessment of sickle cell disease as a prelude to neonatal screening in Ibadan, Nigeria. J Glob Health Rep. 2019;3:e2019062. doi:10.29392/joghr.3.e2019062
   Google Scholar
• Agofure O, Danzaria MA. Knowledge and attitude towards premarital genotype screening among women of child-bearing age in kumo akko local government area of Gombe State. Open J Med Res. 2020;1(1):10–19. doi:10.52417/ojmr.v1i1.73
   Google Scholar
• Owolabi RS, Alabi P, Olusoji D, Ajayi S, Otu T, Ogundiran A. Knowledge and attitudes of secondary school students in Federal Capital Territory (FCT), Abuja, Nigeria towards sickle cell disease. Niger J Med. 2011;20(4):479–485.
   PubMedGoogle Scholar
• Daak AA, Elsamani E, Ali EH, et al. Sickle cell disease in western Sudan: genetic epidemiology and predictors of knowledge attitude and practices. Trop Med Int Health. 2016;21(5):642–653. doi:10.1111/tmi.12689
   PubMed Web of Science ®Google Scholar
• Rasheed TO, Afolabi WA, Abdul Rasheed RO, Ajala RA. Premarital sickle cell genetic screening knowledge, attitude and practice compared among married and unmarried youths in Nigeria. World J Public Health. 2018;3(3):76–82. doi:10.11648/j.wjph.20180303.12
   Google Scholar
• Oluwadamilola AD, Akinreni TI, Adefisan MA, Olayiwola SD. Knowledge, attitude and control practices of sickle cell diseases among senior secondary students in Osun State, Nigeria. Pan Afr Med J. 2021;38:350. doi:10.11604/pamj.2021.38.350.20894
   PubMed Web of Science ®Google Scholar
• Abdulhameed A, Yalma RM. Knowledge, attitude, and practice of genotype screening among junior and senior secondary school students in gwagwalada area council, FCT Abuja. Int J Prog Sci Technol. 2021;26(2):272–280.
   Google Scholar
• Ezenwosu OU, Chukwu BF, Ezenwosu IL, Ikefuna AN, Emodi IJ, Ezeanolue EE. Knowledge and awareness of individual sickle cell genotype among adolescents in a unity school in Southeast, Nigeria: a cross-sectional study. Int J Adolesc Med Health. 2020;20190149. doi:10.1515/ijamh-2019-0149
   Google Scholar
• Faremi AF, Olatubi IM, Lawal YR. Knowledge of sickle cell disease and pre marital genotype screening among students of a tertiary educational institution in south western Nigeria. Int J Caring Sci. 2018;11(1):285–295.
   Google Scholar
• Uche E, Olowoselu O, Augustine B, et al. An assessment of knowledge, awareness, and attitude of undergraduates toward sickle cell disease in Lagos, Nigeria. Niger J Med. 2017;58(6):167. doi:10.4103/nmj.NMJ_111_18
   Google Scholar
• Bosah CN, Alagbu CE. Knowledge and attitude of Nnamdi Azikiwe University undergraduate students towards pre-marital sickle cell screening. J Early Child Prim Educ. 2020;2(1):87–99.
   Google Scholar
• Chukwurah EF, Oduma FC, Madubuattah CG, Chukwurah FC. Assessment of knowledge and attitude of sickle cell genetic screening among fresh undergraduate students of Ebonyi State University, NigeriaAbakaliki. J Med Lab Sci. 2019;29(3):8–20.
   Google Scholar
• Kehinde ME, Sowunmi C. Sickle cell disease knowledge, premarital genotype screening and marital decision among unmarried students of Lagos state Polytechnic Ikorodu, Lagos, Nigeria. EASIJ. 2021;3(5):53–65. doi:10.5281/zenodo.4768648
   Google Scholar
• Yalma RM, Awodiji MM. Knowledge, attitude and practice of genotype screening among undergraduate students of the university of Abuja, Nigeria. Eur J Prev Med. 2021;9(2):63–70. doi:10.11648/j.ejpm.20210902.16
   Google Scholar
• Oludare GO, Ogili MC. Knowledge, attitude and practice of premarital counseling for sickle cell disease among youth in Yaba, Nigeria. Afr J Reprod Health. 2013;17(4):175–182.
   PubMedGoogle Scholar
• Adegbite OA. Young people’s knowledge of sickle cell disease and willingness for genotype screening in Ibadan, Nigeria. Afr J Biomed Res. 2021;24(2):211–217.
   Google Scholar
• Oluwole EO, Adeyemo TA. Knowledge, attitude and willingness to screen younger infants for sickle cell disease among mothers attending immunization clinic in an urban community in Lagos, Nigeria. J Comm Med Prim Health Care. 2021;33(2):52–67. doi:10.4314/jcmphc.v33i2.4
   Google Scholar
• Abubakar SB, Abdulqadir I, Magaji BA, Sanusi N, Ibrahim F, Maiturare M. Knowledge, attitude and perception of traditional and religious leaders on pre-marital screening for sickle cell disease in Sokoto. Int J Med Public Health. 2019;9(2):36–41. doi:10.5530/ijmedph.2019.2.10
   Google Scholar
• Ross PT, Lypson ML, Ursu DC, Everett LA, Rodrigues O, Campbell AD. Attitudes of Ghanaian women toward genetic testing for sickle cell trait. Int J Gynaecol Obstet. 2011;115(3):264–268. doi:10.1016/j.ijgo.2011.08.004
   PubMed Web of Science ®Google Scholar
• Appiah S, Korsah KA, AmpongAdjei C, Appiah OE. Genetic counselling in sickle cell disease: views of single young adults in Ghana. J Community Genet. 2020;11(4):485–493. doi:10.1007/s12687-020-00474-4
   PubMed Web of Science ®Google Scholar
• Nakazwe E, Mwanakasale V, Siziya S. Knowledge attitude and practices of parents with children suffering from sickle cell disease towards factors that precipitate sickle cell crises, at arthur davidson children’s hospital in Ndola Zambia. Asian Pac J Health Sci. 2017;18:18–27. doi:10.21276/apjhs.2017.4.3.26
   Google Scholar
• Olatunya OS, Ogundare EO, Fadare JO, et al. The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria. CEOR. 2015;7:545. doi:10.2147/CEOR.S86599
   Google Scholar
• Amendah DD, Mukamah G, Komba A, Ndila C, Williams TN. Routine paediatric sickle cell disease (SCD) outpatient care in a rural Kenyan hospital: utilization and costs. PLoS One. 2013;8(4):e61130. doi:10.1371/journal.pone.0061130
   PubMed Web of Science ®Google Scholar
• Olatunya OS, Babatola AO, Ogundare EO, et al. Perceptions and practice of early diagnosis of sickle cell disease by parents and physicians in a southwestern state of Nigeria. Sci World J. 2020;2020:4801087. doi:10.1155/2020/4801087
   Google Scholar
• Nnodu OE, Adegoke SA, Ezenwosu OU, et al. A multi-centre survey of acceptability of newborn screening for sickle cell disease in Nigeria. Cureus. 2018;10(3). doi:10.7759/cureus.2354
   PubMedGoogle Scholar
• Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5(1):1–6. doi:10.1186/1756-0500-5-396
   PubMedGoogle Scholar
• Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. J Am Soc Hematol. 2010;115(26):5300–5311. doi:10.1182/blood-2009-04-146852
   Google Scholar
• Adzu B, Masimirembwa C, Mustapha KB, Thelingwani R, Kirim RA, Gamaniel KS. Effect of NIPRISAN® on CYP3A4 activity in vitro. Eur J Drug Metab Pharmacokinet. 2015;40(1):115–118. doi:10.1007/s13318-014-0173-1
   PubMed Web of Science ®Google Scholar
• Nnodu O, Isa H, Nwegbu M, et al. HemoType SC, a low-cost point-of-care testing device for sickle cell disease: promises and challenges. Blood Cells Mol Dis. 2019;78:22–28. doi:10.1016/j.bcmd.2019.01.007
   PubMed Web of Science ®Google Scholar
• Olatona FA, Odeyemi KA, Onajole AT, Asuzu MC. Effects of health education on knowledge and attitude of youth corps members to sickle cell disease and its screening in Lagos State. J Community Med Health Educ. 2012;2:163. doi:10.4172/2161-0711.1000163
   Google Scholar